Seoul
South Korea
4
2023-05-18
3
2023-04-18
These are the the leading inventors for applications assigned to ICM CO., LTD.:
ICM CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PHARMACEUTICAL COMPOSITION FOR TREATING RETINAL DYSTROPHIES, COMPRISING NKX3.2 AND FRAGMENT THEREOF AS ACTIVE INGREDIENTS
#2 | 2021-06-24 ✅ Patent 11,628,203 granted on 2023-04-18Pharmaceutical composition for treating retinal dystrophies, comprising Nkx3.2 and fragment thereof as active ingredients
#3 | 2020-06-18 ✅ Patent 11,154,590 granted on 2021-10-26Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
#4 | 2019-11-21 ✅ Patent 11,235,025 granted on 2022-02-01Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
Also check out ICM CO., LTD.'s (Seoul, South Korea) applicant profile with 3 patent applications submitted.
159579 ⎘